New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
06:41 EDTJNJSurgeon told by J&J sales rep of hip implant troubles, Bloomberg reports
A surgeon in Montana testified that he stopped using Johnson & Johnsonís (JNJ) ASR all-metal hip device eight months before the company recalled it because a sales rep warned about problems with the implant by, reports Bloomberg. Peter Wendt, testified that he implanted 76 ASRs, including one in Loren Kransky, 65, of Montana. Kranskyís lawsuit is the first of 10,000 to go to trial over claims that J&Jís DePuy unit defectively designed the 93,000 hips recalled in August 2010 and failed to warn of the risks. J&J, denies that it defectively designed the device or that it contributed to the health problems of Kransky. Reference Link
News For JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 17, 2015
07:21 EDTJNJGeneric ADHD drugs still sold despite FDA non-equivalance finding, NYT reports
The FDA announced last November that two generic versions of Johnson & Johnson's (JNJ) Concerta ADHD drug, one made by Mallinckrodt (MNK) and the other by UCB, could no longer be considered the equivalent of the branded drug after tests and analyses suggested that their effectiveness began to wear off much more quickly, but the drugs are still being sold despite an FDA mandated deadline having passed for the companies to either prove the drugs were equivalent or remove them from the market, said The New York Times. The report noted a third generic product, sold by Actavis (AGN), was found to be equivalent to the branded Concerta. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use